Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pezza

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Minerva Anestesiologica|November 2, 2004
Use of quinupristin/dalfopristin in a critical patient with a methicillin-resistant Staphilococcus aureus infectionE De Robertis, D Viscidi, G Servillo, et al.
Australian Dental Journal|May 29, 2009
The use of etanercept as a non-surgical treatment for temporomandibular joint psoriatric arthritis: a case reportL Lamazza, F Guerra, M Pezza, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 6, 2002
Neurofibromatosis type I and Arnold-Chiari malformationS Giustini, A Richetta, L Divona, et al.
International Journal of Immunopathology and Pharmacology|September 21, 2007
Re-induction as a possible alternative modality of dose escalation of infliximab: a prospective evaluation in a small series of psoriatic patientsN Cassano, A Puglisi Guerra, C Malara, et al.
La Clinica Terapeutica|June 15, 2007
PEL, Kaposi's sarcoma HHV8+ and idiopathic T-lymphocitopenia CD4+A Richetta, G F Amoruso, V Ascoli, et al.
International Journal of Immunopathology and Pharmacology|October 15, 2010
Treatment of psoriasis with different dosage regimens of etanercept: preliminary results from the Tαranta Plastic Study GroupN Cassano, F Loconsole, A Miracapillo, et al.
International Journal of Immunopathology and Pharmacology|June 10, 2009
The safety of anti-TNF agents in the elderlyA Migliore, E Bizzi, B Laganà, et al.
International Journal of Immunopathology and Pharmacology|March 25, 2009
A multicenter open-label experience on the response of psoriasis to Adalimumab and effect of dose escalation in non-responders: the Aphrodite projectG A Vena, A Galluccio, C De Simone, et al.
Techniques in Coloproctology|August 19, 2023
Five-year recurrence after endoscopic approach to pilonidal sinus disease: A multicentre experienceM Manigrasso, A D'Amore, E Benatti, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Minerva Anestesiologica|November 2, 2004
Use of quinupristin/dalfopristin in a critical patient with a methicillin-resistant Staphilococcus aureus infectionE De Robertis, D Viscidi, G Servillo, et al.
Australian Dental Journal|May 29, 2009
The use of etanercept as a non-surgical treatment for temporomandibular joint psoriatric arthritis: a case reportL Lamazza, F Guerra, M Pezza, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 6, 2002
Neurofibromatosis type I and Arnold-Chiari malformationS Giustini, A Richetta, L Divona, et al.
International Journal of Immunopathology and Pharmacology|September 21, 2007
Re-induction as a possible alternative modality of dose escalation of infliximab: a prospective evaluation in a small series of psoriatic patientsN Cassano, A Puglisi Guerra, C Malara, et al.
La Clinica Terapeutica|June 15, 2007
PEL, Kaposi's sarcoma HHV8+ and idiopathic T-lymphocitopenia CD4+A Richetta, G F Amoruso, V Ascoli, et al.
International Journal of Immunopathology and Pharmacology|October 15, 2010
Treatment of psoriasis with different dosage regimens of etanercept: preliminary results from the Tαranta Plastic Study GroupN Cassano, F Loconsole, A Miracapillo, et al.
International Journal of Immunopathology and Pharmacology|June 10, 2009
The safety of anti-TNF agents in the elderlyA Migliore, E Bizzi, B Laganà, et al.
International Journal of Immunopathology and Pharmacology|March 25, 2009
A multicenter open-label experience on the response of psoriasis to Adalimumab and effect of dose escalation in non-responders: the Aphrodite projectG A Vena, A Galluccio, C De Simone, et al.
Techniques in Coloproctology|August 19, 2023
Five-year recurrence after endoscopic approach to pilonidal sinus disease: A multicentre experienceM Manigrasso, A D'Amore, E Benatti, et al.
Pageof 3